MAKING THE CONNECTION

Between Patients and Providers VIRTUAL EDITION

An Interactive Online Continuing Medical Education Conference Experience For MDs, NPs/PAs, CDCESs, RNs, PharmDs and ALL YOU HEALTHCARE PROS!

Open-Book-Icon

Cutting-Edge Education

Speaker-Icon

Interactive 6-hour Program

CME-Credits-Icon

Earn Educational Credits

Stethescope-Icon

Live Q+A With Expert Speakers

Lightbulb-Template

Network with Professionals

Icon-Finger

Lectures On-Demand 30 Days*

An interactive EDUCATIONAL conference experience for Healthcare Professionals FROM AROUND THE WORLD…with expert speakers, re-watchable lectures and live Q&A during every presentation!

Healthcare professionals who attend Making the Connection will…

•  Learn from the nation’s leading experts in diabetes treatment
•  Participate in a fun and interactive format 
•  Get their questions answered in live Q&A discussion panels
•  Earn continuing education credits (see full accreditation info here)
•  Network with Healthcare Professionals from around the world
•  Help patients reach treatment goals

WHAT YOU WILL LEARN

We focus on five distinct areas of the most cutting-edge diabetes management strategies:

1.  Understanding the emotional and behavioral issues that affect adherence and glycemic control in people living with diabetes
2.  Lowering Cardiorenal Risk While Improving Glycemic Control with oral agents: Understanding and effective use of the new ADA treatment algorithm.
3.  Practical Application of individualized insulin strategies and a close look at the cardiovascular effects of the GLP1-RAs
4.  A Focus on Time in Range, Unmet Needs & Modern Management of Type 1 Diabetes: continuous glucose monitors, insulin pumps, hybrid closed loop systems, adjunctive therapies and techniques to improve time in range
5.  Diabetes criminals and the diabetes police: A workshop to focus on the provider patient relationship

“Thank you for an EXCELLENT program filled with CUTTING-EDGE information around diabetes and also for spending time on the important issue of PROVIDER/PATIENT RELATIONSHIP.”

Meet TCOYD’s Founder & Director

Dr. Steven V. Edelman is a Clinical Professor of Medicine at University of California, San Diego (UCSD) School of Medicine, the Director of the Diabetes Care Clinic at the VA Medical Center in San Diego and a type 1 since the age of 15. He’s dedicated his medical career to bringing diabetes education and cutting-edge management strategies directly to the people who need it most, people who have diabetes and the medical professionals who treat them.

PRESENTED BY THE NATION’S LEADING DOCTORS & RESEARCHERS

Making the Connection Planning Committee:

STEVEN V. EDELMAN, MD
Endocrinologist, Founder & Director, TCOYD; Clinical Professor of Medicine, University of California, San Diego (UCSD) School of Medicine; Director, Diabetes Care Clinic, VA Medical Center San Diego
JEREMY H. PETTUS, MD
Endocrinologist, Type 1 Track Co-Director, TCOYD; Associate Professor of Medicine, University of California, San Diego (UCSD) School of Medicine
WILLIAM POLONSKY, PHD, CDCES
President, Behavioral Diabetes Institute; Associate Clinical Professor, Department of Psychiatry, University of California San Diego
TRICIA SANTOS CAVAIOLA, MD
University of California, San Diego School of Medicine
SCHAFER BOEDER, MD
University of California, San Diego School of Medicine

ACCREDITATION INFORMATION

Learning Objectives

At course completion, participants should be able to:

  1. Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities. 
  2. Discuss the recently published cardiovascular-renal outcome trials on oral (SGLT2 inhibitors) and injectable type 2 medications (GLP1-RAS). 
  3. Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD). 
  4. Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach. 
  5. Design a treatment plan for multiple daily injection regimens and insulin pump therapy including hybrid closed loop systems. 
  6. Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation. Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s). 
  7. Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes. 

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Uni­versity of California San Diego School of Medicine and Taking Control of Your Diabetes. The University of California San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA: The University of California San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Cate­gory 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the Califor­nia Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to 6.0 hours of credit and list “CME Category 1” as the provider number).

Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Phy­sician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.

Certified Diabetes Care and Education Specialists: To satisfy the requirement for renewal of certification by continuing education for the Certification Board for Diabetes Care and Education (CBDCE) continuing education activities must be diabetes related and approved for a provider on the CBDCE list of approved providers (cbdce.org). CBDCE does not approve continuing education. The University of California San Diego is accredited by the ACCME, which is on the CBDCE list of approved providers.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education.  (Universal Activity Number – 0530-9999-21-015-L01-P)

This is a knowledge based activity.

Attention HCPs from outside of the US: To see if you are eligible to receive CME credits check here.

Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources can be found on the UC San Diego CME website.

Acknowledgement of Commercial Support

This activity is supported by educational grants from:
Amarin Pharma Inc., AstraZeneca, Dexcom, Lilly USA, LLC,
Medtronic Diabetes, Merck Sharp & Dohme Corp, NovoNordisk, Inc., and Xeris Pharmaceuticals, Inc.

This activity is jointly provided by Taking Control Of Your Diabetes, UC San Diego School of Medicine, and Global Education Group.

tcoyd-ucsd-global-logos-2020